Skip to main content
. 2023 Jun 28;43(7):808–833. doi: 10.1002/cac2.12428

FIGURE 3.

FIGURE 3

Cdh16‐Cre/Mfn2 flox/flox mice develops malignant lesions and exhibits EGFR signaling pathway activation. (A) Experimental scheme for generating the Mfn2 CKO mice. (B) Representative images of kidneys of Mfn2 CKO and control Mfn2 flox/flox mice taken at 40 weeks of age. (C) Representative H&E staining of kidney sections of 40‐week‐old control and Mfn2 CKO mice. (D) Representative H&E staining of kidney sections. (i) H&E staining of control mice display normal kidney morphology. (ii‐vi) H&E staining of kidney sections of Mfn2 CKO mice shows solid dysplasia (ii), clear cytoplasm (iii), a simple cyst lined by a single epithelial layer (iv), a cyst showing atypical epithelial cell proliferation (multi‐layered) (v) and a cyst showing extensive proliferation of epithelial cells into the cyst lumen (vi). (E) Representative IHC staining images of p‐EGFR, p‐AKT and p‐ERK in kidney sections of control and Mfn2 CKO mice (n = 3 per group). IHC scores are shown. (F) Western blotting analysis of indicated proteins in EGF‐treated primary renal tubular epithelial cells isolated from control and Mfn2 CKO mice. (G) Representative H&E staining of kidney sections from Ctrl, Vhl CKO, Mfn2 CKO and VhlMfn2 CKO mice.

Abbreviations: Mfn2 CKO, Cdh16‐Cre/Mfn2 flox/flox mice; CKO, conditional knockout; Ctrl, control Mfn2 flox/flox mice; H&E, hematoxylin and eosin; EGF, epidermal growth factor; Vhl, Von Hippel‐Lindau Tumor Suppressor; Vhl CKO, Cdh16‐CreVhl flox/flox mouse; VhlMfn2 CKO, Cdh16‐Cre/Vhl flox/flox /Mfn2 flox/flox mice.